期刊
CORTEX
卷 157, 期 -, 页码 304-322出版社
ELSEVIER MASSON, CORP OFF
DOI: 10.1016/j.cortex.2022.10.001
关键词
Primary progressive aphasia; Executive functions; Meta-analysis; Neuropsychology; Dementia; Neurolinguistics
资金
- Research Foundation-Flanders (FWO)
- Junior Research Project [FWOAL938]
- Science of Learning Institute at Johns Hopkins University
- NIH/NIDCD [R01 DC014475]
- NIH/NIA [R01 AG068881]
This study conducted a multi-level meta-analysis to investigate deficits in executive functions (EFs) in Primary Progressive Aphasia (PPA) patients. The results showed that PPA patients had poorer EFs compared to age-matched cognitively healthy controls. There were no significant differences between the effect sizes of different EFs components, indicating similar impairments across all components. PPA variant and disease duration were found to be significant moderators of performance.
Executive functions (EFs) refer to a set of cognitive processes, specifically shifting, inhibition, updating of working memory, and are involved in the cognitive control of behavior. Conflicting results have been reported regarding impairments of EFs in Primary Progressive Aphasia (PPA). We performed a multi-level meta-analysis to confirm whether deficits of EFs exist in this population, focusing on a common EFs composite, and the components shifting, inhibition and updating separately. We included 141 studies that report on 294 EFs tasks. The overall mean weighted effect size was large (d = -1,28), indicating poorer EFs in PPA as compared to age-matched cognitively healthy controls. Differences between effect sizes of the EFs components were not significant, indicating all components are affected similarly. Overall, moderator analysis revealed that PPA variant and disease duration were significant moderators of performance, while task modality and years of education were not. The non-fluent/agrammatic PPA and the logopenic PPA variants were similarly affected, but the semantic variant was affected to a lesser extent. We discuss implications for clinical and research settings, and future research. (c) 2022 Published by Elsevier Ltd.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据